MENU
PMN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Promis Neurosciences (PMN) Earnings Date & Reports
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimers disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA)... Show more
A.I. Advisor
published Earnings
PMN is expected to report earnings to fall 1.56% to -125 cents per share on November 11
Q3'26
Est.
$-1.26
Q2'26
Missed
by $1.10
Q1'26
Missed
by $1.08
Q4'25
Missed
by $1.05
Q3'25
Est.
$-0.24
The last earnings report on August 13 showed earnings per share of -127 cents, missing the estimate of -18 cents. With 1.21K shares outstanding, the current market capitalization sits at 81.88M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
1920 Yonge Street
Phone
+1 416 847-6898
Employees
11
Web
https://www.promisneurosciences.com